The economics of HIV/AIDS in low-income countries: the case for prevention.
Canning
David
D
Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA. dcanning@hsph.harvard.edu
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D003140:Communicable Disease Control; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003906:Developing Countries / Q000191:economics; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy / Q000635:transmission; D005102:Health Expenditures; D006801:Humans; D011203:Poverty; D015995:Prevalence; D011634:Public Health / Q000191:economics
D044966:Anti-Retroviral Agents